Article
The NKCC1 inhibitor bumetanide has no discernible effect on plasma cell survival, persistence or antibody secretion
2026-05-26
Abstract excerpt
Long-lived plasma cells (LLPC) sustain humoral immunity but also contribute to the persistence of pathogenic autoantibodies in autoimmune diseases. New therapies targeting LLPC are therefore desirable. Recent studies have shown increased expression of Slc12a2 , encoding the Na + -K + -Cl − cotransporter (NKCC1), in LLPC. This study investigated whether NKCC1 activity was required for plasma cell survival, pers...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c31c49f8-c6fa-5a98-a39d-83532749f0fc
- DOI
- 10.64898/2026.05.22.727109
